Pusic I, Miklos D, Cutler C, et al. Ibrutinib for chronic graft-versus-host disease after failure of frontline corticosteroids: results of a multicenter open-label phase 2-study. EHA 2017, S492.
Emicizumab-profylaxe bij hemofilie-A met remmers: HAVEN 1
jul 2017 | Benigne hematologie